Cellular mechanisms of progression of chronic kidney disease: level of monocytic chemoattractive protein (МСР1) depending on genesis of glomerular lesions and its dynamics under the influence of complex treatment
For the clinical monitoring 305 patients with primary and secondary glomerular lesions patterns of level of monocytic chemoattractive protein (МСР1) depending on the genesis of glomerular lesions and stages of chronic kidney disease and its dynamics under the influence of complex treatment are studied, which was supposed to be included in the angiotensin-converting enzyme inhibitor therapy, statins and and keto-analogue of essential amino acids.